FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

IntegraDose Compounding Services fentaNYL Citrate 2 Recall

fentaNYL Citrate 2,500 mcg/50mL in Sterile Water, 50 mL CADD for Injection, IntegraDose…

IntegraDose Compounding Services LLC · Minneapolis, MN

Risk level
Class II
Reported by FDA
Apr 10, 2024
Recall ID
D-0432-2024
Check your lot numberHow we source this data

Summary

IntegraDose Compounding Services recalled fentaNYL Citrate 2 starting Mar 22, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0432-2024 on Apr 10, 2024. Reason: Lack of Assurance of Sterility: leaking bags. Status: Ongoing.

Why it was recalled

Lack of Assurance of Sterility: leaking bags

Product description

fentaNYL Citrate 2,500 mcg/50mL in Sterile Water, 50 mL CADD for Injection, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-6030-1

Lot numbers, UPCs & expiration codes

Lot#: 20231020FEN-1, Exp: 04/17/2024

Where it was sold

Nationwide within the U.S

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0432-2024
Classification
Class II
Status
Ongoing
Recall initiated
Mar 22, 2024
FDA report date
Apr 10, 2024
Quantity
187 cassettes
Recall type
Voluntary: Firm initiated
Recalling firm
IntegraDose Compounding Services LLC

Original FDA data

Every field from FDA enforcement report D-0432-2024, exactly as published.

Show all FDA fields
City
Minneapolis
State
MN
Status
Ongoing
Country
United States
Event ID
94275
Address
719 Kasota Ave Se
Code information
Lot#: 20231020FEN-1, Exp: 04/17/2024
Postal code
55414-2842
Report date
Apr 10, 2024
Product type
Drugs
Recall number
D-0432-2024
Classification
Class II
Recalling firm
IntegraDose Compounding Services LLC
Product quantity
187 cassettes
Reason for recall
Lack of Assurance of Sterility: leaking bags
Voluntary / mandated
Voluntary: Firm initiated
Product description
fentaNYL Citrate 2,500 mcg/50mL in Sterile Water, 50 mL CADD for Injection, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-6030-1
Distribution pattern
Nationwide within the U.S
Recall initiation date
Mar 22, 2024
Initial firm notification
Letter
Center classification date
Apr 3, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0432-2024, published Apr 10, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls